Genentech's Business Model

Joe McCracken, Genentech

Loading video...

Joe McCracken, Vice President of Business Development at Genentech, describes Genentech's business model where commercialization takes a back seat to science. He differentiates this from other typical pharmaceutical companies and shows how this affects the culture at Genentech. He credits this approach for the successful innovation of several hugely profitable drugs.

Nov 30, 2006

More from this event

More on this topic